REIMAGINING WHAT’S POSSIBLE IN BIOPHARMA
Developing Tomorrow’s Therapies with Speed, Impact, and Purpose
VivaMed BioPharma is advancing drug development to deliver high-impact therapies for urgent health needs, such as pain, addiction, neurodegeneration, and rare diseases. We combine artificial intelligence, global partnerships, and decades of clinical and operational experience to bring better treatments to the people who need them most.
An Engineered Model for Lower-Risk, Faster-to-Market Drug Development
At VivaMed, we combine regulatory expertise, AI-assisted modeling, and a strategically balanced portfolio of new and repurposed drug assets. This approach lets us identify high-potential therapies early, reduce attrition through smarter development, and scale innovation without the timelines and capital demands of traditional pharma models.
OUR PILLARS OF INNOVATION
How We De-Risk, Accelerate,
and Advance What Matters
De-Risked and Diversified
We manage a global portfolio of new and repurposed drug assets across multiple therapeutic areas and development stages—reducing risk while expanding opportunity and impact.
AI at Every Stage
Our proprietary AI platform accelerates discovery, predicts safety and efficacy, and automates IP and regulatory drafting—cutting time and cost from preclinical to commercialization.
Partnering for Progress
With over 30 academic and industry partners across 13 countries, we collaborate with world-class researchers to identify breakthroughs early and bring them to life faster.
STRATEGIC FOCUS, REAL-WORLD IMPACT
We’re not chasing pipelines. We’re fixing what’s broken.
Millions are Slipping Through the Cracks
Mild Cognitive Impairment and Alzheimer’s affect tens of millions worldwide. Most options are too late—or too weak. We focus on early-stage neuroplasticity therapies designed to slow decline before it becomes irreversible.
Chronic Pain is a Public Health Crisis
Over 20 million Americans suffer from neuropathic pain. Post-operative opioid use remains a major driver of addiction. We’re developing non-opioid treatments that provide lasting relief—without creating new problems.
The System Fails Dual-Diagnosis Patients
Substance use and trauma are deeply connected, yet rarely treated together. Our therapies address addiction and PTSD in tandem—starting with veterans, frontline workers, and others left behind by traditional care models.
Rare Doesn’t Mean Untreatable
Millions live with rare diseases that have no approved treatments. We accelerate repurposed and orphan-class therapies to bring solutions forward—where time and access are everything.
Still No FDA-Approved ARDS Therapies
Acute Respiratory Distress Syndrome kills up to 40% of those diagnosed. Long-term survivors often face irreversible lung damage. We’re advancing first-in-class biologics to change the standard of care—because supportive care isn’t a strategy.
Breakthroughs Don’t Happen Alone
At VivaMed, partnerships are core to how we operate—and why we succeed. We collaborate with over 30 academic institutions, biotech innovators, and clinical research teams across 13 countries. These relationships help us identify promising science early, accelerate development, and bring high-need therapies to market with precision and speed. Whether you’re a research institution, technology company, or mission-aligned investor—there’s a place for you in what we’re building.
- 30+ university and research partners
- Collaborations across 13 countries
- Early access to breakthrough compounds and clinical programs
MOMENTUM
Proven Execution Across Programs, Platforms, and Partners
With decades of combined experience and a globally distributed model, VivaMed has the infrastructure, expertise, and momentum to bring high-impact therapies to life—efficiently and at scale.
- 150+ drug assets licensed or developed
- 39 regulatory approvals supported
- Offices in 5 countries across 3 continents
TEAM
From Clinical Trials to Company Exits—We’ve Done This Before
Our leadership team combines deep clinical, technical, and operational expertise with a track record of real outcomes. We’ve launched biotech startups, led drug approvals, built AI platforms, and guided exits worth hundreds of millions. Now we’re applying that experience to fix what’s broken in drug development—and deliver therapies that matter.
Global. Agile. Mission-Aligned.
We’re not here to theorize—we’re here to deliver.
40+
Years as Healthcare Entrepreneurs Scaling Startups
25+
Years Partnering with Research Universities, Companies, and Private Equity
Presence Around the World
Headquarters & Offices Worldwide
CONTACT
Let's Connect
Have a question, opportunity, or idea? Whether you’re a researcher, investor, or potential partner—we’d love to hear from you.